NOVADAQ Enters Into Agreement to be Acquired by Stryker Corporation

NOVADAQ Technologies Inc. (NASDAQ:NVDQ) (TSX:NDQ) the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, today announced that it has entered into a definitive arrangement  with Stryker Corporation to acquire all of the issued and outstanding shares of NOVADAQ.

This transformative transaction recognizes the exceptional value we have built at NOVADAQ. Moreover, we believe it creates a strong opportunity for NOVADAQ, its customers, partners, shareholders and employees. I am proud of the impact our SPY and PINPOINT technology has made throughout the world in breast reconstruction and colorectal surgery, as well as other minimally invasive applications, and look forward to the additional progress we can make as part of Stryker’s organization.
— Rick Mangat, President and Chief Executive Officer, NOVADAQ